They don't even include the specific amount of the grant. :-(
Suppose the next quarterly filing will include this.
Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has received funding from the Bill & Melinda Gates Foundation to support the demonstration of its ability to deliver a human immunodeficiency virus ("HIV") preventative therapeutic and a contraceptive from a single implant using its proprietary ProNeura(R) technology, and ensure this technology is accessible to women and adolescent girls in low- and middle-income countries.